RxDoctor Payments Data

Rose Marie Shaw Bullock, MD

Family Medicine · N Little Rock, ARNPI 1790749943

Payments from drug & device makers

$699in general payments, 2019–2025

Across 44 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$162
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
  • AstraZeneca$80
  • Novo Nordisk$51
  • Pfizer$50
  • Merck$39
  • plus $231 from 12 others

What the payments were for

  • Food & beverage$699100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$699 in reported general payments places this provider in the 50th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$30,030
Medicare patients
97
Services billed
741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide92$90,279
JardianceEmpagliflozin45$46,215
FarxigaDapagliflozin Propanediol33$29,901
EliquisApixaban32$26,868
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$21,737
MounjaroTirzepatide19$20,562
JanuviaSitagliptin Phosphate20$19,487
XareltoRivaroxaban15$17,158
EntrestoSacubitril/Valsartan11$12,633
SymbicortBudesonide/Formoterol Fumarate28$6,974
Albuterol Sulfate HfaAlbuterol Sulfate188$5,547
Gabapentin198$3,593
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,584
Varenicline Tartrate15$3,148
Insulin Lispro Kwikpen U-100Insulin Lispro11$2,463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$90,27992 claims
AstraZenecaFarxiga, Symbicort$80$36,87661 claims
PfizerEliquis$50$26,86832 claims
GSKTrelegy Ellipta$162$21,73726 claims
Lilly USA, LLCMounjaro$16$20,56219 claims
MerckJanuvia$39$19,48720 claims
NovartisEntresto$16$12,63311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in N Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →